| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
1 Department of Radiology, Eastbourne District General Hospital, East Sussex
BN21 2UD, United Kingdom.
2 Department of Maxillofacial Surgery, Eastbourne District General Hospital,
King's Dr., Eastbourne, East Sussex BN21 2UD, United Kingdom.
3 Department of Ear, Nose and Throat Surgery, Eastbourne District General
Hospital, Eastbourne, East Sussex, BN21 2UD, United Kingdom.
Received September 1, 2005;
accepted after revision December 7, 2005.
Address correspondence to D. C. Howlett
(David.Howlett{at}ESHT.NHS.UK).
Abstract
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
SUBJECTS AND METHODS. Between 1998 and 2004, 135 patients consecutively presenting with a parotid mass were prospectively enrolled into this study. A single operator performed initial diagnostic sonography and then sonographically guided core biopsy using local anesthesia. Biopsy was performed with an 18- or 20-gauge needle and a spring-loaded biopsy gun with a mean of two passes per patient. Outcome measures were accuracy, sensitivity, specificity, and predictive values of sonographically guided core biopsy compared with the final pathologic diagnosis in the surgical group. In the nonsurgical group, final diagnosis was established on the basis of histologic findings after adequate core biopsy and clinical follow-up.
RESULTS. All sonographically guided core biopsy specimens were considered satisfactory for histologic evaluation. Overall there were 71 benign tumors, 35 malignant tumors, and 29 miscellaneous, nonneoplastic lesions. In 76 (56%) of the 135 patients who underwent surgery, sonographically guided core biopsy and surgical histologic findings were correlated for 74 patients. In two cases sonographically guided core biopsy and surgical histologic findings did not correlate. In one case, the sonographically guided core biopsy finding was mucoepidermoid carcinoma, but the final diagnosis was squamous cell carcinoma. In the other case, the finding at sonographically guided core biopsy was squamous cell carcinoma, but the final diagnosis was mucoepidermoid carcinoma. The treatment of these patients was not affected. Fifty-nine (44%) of the 135 patients avoided surgery. In differentiation of benign from malignant disease, sonographically guided core biopsy had a sensitivity, specificity, and diagnostic accuracy of 100%. Sonographically guided core biopsy also had positive and negative predictive values of 100% in the diagnosis of malignancy. There were no significant complications of sonographically guided core biopsy.
CONCLUSION. Sonographically guided core biopsy is a highly accurate technique for evaluation of parotid lesions and can be safely performed as an outpatient procedure. Sonographically guided core biopsy has potential advantages over fine-needle aspiration cytologic examination, particularly in the typing and grading of lymphoma and carcinoma and in improved differentiation of reactive nodal hyperplasia from lymphoma. The use of sonographically guided core biopsy may help reduce the need for surgical biopsy and facilitates prompt referral to the appropriate clinical team.
Keywords: head and neck imaging • head and neck radiology • parotid gland • sonography
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
After the fall from favor of open biopsy as the result of a high level of tumor seeding [1], fine-needle aspiration cytology (FNAC) has been widely adopted for assessment of parotid masses. High diagnostic accuracy has been found in some studies [2-6]. FNAC has well-documented limitations, however, and is frequently associated with high levels of inadequate or false-negative diagnoses [7, 8]. It is against this background that sonographically guided core biopsy of the parotid gland has been investigated [9-11]. Previous studies involved 16 [9], 54 [10], and 53 [11] patients with parotid swelling and showed a diagnostic accuracy of 97% [10, 11] to 100% [9] for sonographically guided core biopsy findings compared with surgical histologic findings, and there were no significant complications. In two of the studies [9, 10], 18-gauge or smaller needles were used with a mean of two passes per patient. In the third study [11], small- and large-bore needles (up to 14-gauge) and a range of needle passes were used. The purpose of our study was to evaluate the accuracy and safety of sonographically guided core biopsy performed only with small-bore needles in a series of 135 patients presenting with a parotid mass.
|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
All parotid lesions were demarcated sonographically as lying in the superficial lobe of the gland and had a size range of 6-58 mm. In most (n = 122) of the patients, 18-gauge needles were used. Because of the hazards of facial nerve and vascular injury, 20-gauge needles were used in patients (n = 13) with smaller lesions situated close to the main intraparotid vessels. Under sonographic guidance, lesions were approached along the longitudinal, oblique, or transverse plane, depending on the position of the lesion and to avoid adjacent structures (Fig. 1). Biopsy specimens of cystic lesions were obtained from the cyst wall, samples being directed at the more solid components of lesions of mixed cystic and solid appearance.
The needle throw of the variable-throw biopsy device was selected according to the size and situation of the lesion to allow adequate lesion sampling but to ensure the needle did not exit deep in relation to the lesion (Figs. 2A and 2B). Most of the biopsy procedures took less than 15 minutes. After biopsy, patients were asked to compress the puncture site and were observed for 30 minutes before discharge.
|
|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
In the surgical group, 55 patients had a diagnosis of benign neoplasm (37, pleomorphic adenoma [Fig. 3]; 16, Warthin's tumor [Fig. 4]; two, oncocytoma). Eighteen patients had a diagnosis of malignancy (three, mucoepidermoid carcinoma [Fig. 5]; one, adenoid cystic carcinoma; two, adenocarcinoma; one, oncocytic carcinoma; two, squamous cell carcinoma; two, poorly differentiated carcinoma; one, melanoma; six, non-Hodgkin's lymphoma). Three patients had miscellaneous, nonneoplastic diagnoses (one, lymphadenitis; one lymphoepithelial cyst; one, actinomycosis).
|
|
|
|
The patient with a core biopsy diagnosis of normal parotid tissue presented with bilateral parotid swelling. At sonography the glands appeared hyperechoic and enlarged, suggestive of fatty infiltration. Biopsy specimens were obtained from the superficial lobe of the right parotid gland. After a normal histology report, no further investigations were undertaken.
There was complete agreement between the results of sonographically guided core biopsy and surgical histologic findings in 74 of 76 patients. The two cases that did not correlate were malignant tumors. One of these tumors was diagnosed as squamous cell carcinoma at sonographically guided core biopsy, but the final histologic result was mucoepidermoid carcinoma. In the other case, the core biopsy diagnosis was mucoepidermoid carcinoma, but the final histologic result was squamous cell carcinoma. The treatment of these two patients was not affected by these findings; both underwent surgical excision.
Only six of 17 patients with a core biopsy diagnosis of non-Hodgkin's lymphoma needed surgical biopsy for further treatment information. The eight patients with reactive nodal hyperplasia diagnosed at sonographically guided core biopsy were well during clinical follow-up. Sixteen patients with benign neoplasms did not undergo surgical treatment. They either declined or were unfit for surgery and continued to undergo observation. Three nonneoplastic lesions were managed surgically either for symptom control or at patient request.
Sonographically guided core biopsy was well tolerated by all patients with no immediate complications. A small subclinical hematoma was present at surgery in one patient who had undergone biopsy of a Warthin's tumor. The hematoma was in the soft tissue overlying the gland at the biopsy site and was impalpable. The patient had no predisposing risk factors for bleeding, and surgery was unaffected. No evidence of tumor seeding was detected during follow-up.
To assess the utility of sonographically guided core biopsy in the diagnose of malignancy and to differentiate benign from malignant disease, we compared histologic results and sonographically guided core biopsy findings for the 76 patients who underwent both biopsy and surgery. There were 18 true-positive findings (malignant diagnosis) and 58 true-negative findings (benign diagnoses) and no false-positive or false-negative findings, giving sonographically guided core biopsy a sensitivity, specificity, and diagnostic accuracy of 100% and 100% positive and negative predictive values in the diagnosis of malignancy.
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
The pitfalls of FNAC have led some authors to study the use of sonographically guided core biopsy in assessment of parotid masses [9-11]. The combination of initial diagnostic sonography with biopsy is useful because the parotid glands are superficial structures, readily amenable to assessment with high-resolution sonography. Sonography is the initial imaging technique of choice for the characterization and delineation of parotid masses, and the findings can be used as a guide for additional imaging (usually MRI) of possibly malignant lesions and of lesions the full extent of which is difficult to assess, particularly if there is deep lobe involvement, an area of sonographic weakness due to mandibular obscuration [19, 20]. The use of sonographic guidance for biopsy is important because it allows accurate needle placement, such that the needle traverses but does not exit deep in relation to the lesion and avoids adjacent structures. A variable throw ability of the biopsy device is useful when space is confined. Some needle devices allow initial passage of the inner stylet for exact positioning of the needle tip, with subsequent discharge of the outer sheath over the fixed inner stylet to obtain a core of tissue. This technique may help reduce damage to deeper structures. Sonographic guidance also allows central sampling of a lesion with improved diagnostic yield [21], and necrotic areas can be bypassed. Sonography may also depict clinically impalpable disease.
In our study, sonographically guided core biopsy had a diagnostic accuracy of 100% in the surgical group, comparable with previous findings. Sonographically guided core biopsy also had 100% sensitivity and specificity in the differentiation of benign from malignant disease and 100% positive and negative predictive values in the diagnosis of malignancy. There was no correlation between sonographically guided core biopsy findings and surgical histologic findings in only two cases, of mucoepidermoid and squamous cell carcinoma, but management was unaffected. In all cases, biopsy specimens with which a diagnosis could be determined were obtained with small-bore needles (18- or 20-gauge) with an average of two passes per patient. Sonographically guided core biopsy was well tolerated with no significant complications. Unlike FNAC, sonographically guided core biopsy requires formal histologic reporting, which is time-consuming, and it is more invasive than FNAC, requiring local anesthesia and a skin incision.
The main advantage of core biopsy over FNAC is that a core of tissue is obtained that can be used for formal histologic and immunohistochemical analysis. This advantage improves differentiation of low-grade lymphoma from reactive nodal hyperplasia, allows grading and typing of lymphoma and poorly differentiated carcinoma, and helps determine the likely origin of metastatic carcinoma. In our study only six (35%) of 17 patients with non-Hodgkin's lymphoma needed surgical biopsy for additional treatment information, and no patient with a core biopsy diagnosis of reactive nodal hyperplasia underwent surgical excision, clinical follow-up sufficing. Eleven patients in whom no focal lesion was detected with sonography underwent sonographically guided core biopsy for evaluation of possible parotid involvement by systemic disease.
Although there were no major complications of sonographically guided core biopsy in our study, there are hazards of core biopsy that need to be considered, including hemorrhage, facial nerve injury, and tumor seeding. The retromandibular vein and external carotid artery are the major intraparotid vessels; they are well visualized with sonography (Fig. 1) and can be avoided [20]. The facial nerve is not readily identified with sonography, although its position can be inferred because the nerve passes in a plane superficial to the retromandibular vein and can be avoided [14, 20].
Tumor seeding along the needle track is a hazard of both FNAC and core biopsy. The risk of tumor seeding varies according to the organ involved and the size of the needle used. Tumor seeding is described in as many as 12% of cases of FNAC of thoracic mesothelioma [22], with an incidence of only 0. 02% for abdominal tumors [23]. Evidence suggests that tumor seeding tends to occur with larger-bore needles, probably because these needles allow aspiration of sizable stromal fragments and allow survival of malignant cells [22]. Tumor seeding in the parotid gland is extremely rare after needle biopsy and has been described only in association with the use of large-bore needles [24]. Some surgeons excise the biopsy track, although this approach has not been adopted at our institution. Although there was no evidence of tumor seeding in our study population, patient follow-up was limited to only a few months in some cases, and continued surveillance is needed.
In conclusion, sonographically guided core biopsy is a highly accurate, safe, and well-tolerated technique for the diagnosis of parotid mass. The procedure can be performed with small-bore needles on an outpatient basis. Sonographically guided core biopsy has advantages over FNAC, particularly in differentiation of lymphoma from reactive nodal hyperplasia, in typing and grading of carcinoma and lymphoma, and in the assessment of parotid involvement by systemic disease. The use of sonographically guided core biopsy may reduce the high rate of surgical biopsy associated with FNAC that does not provide enough information for diagnosis and may facilitate both prompt referral to the relevant clinical team and selection of an appropriate operative procedure if needed.
Acknowledgments
We thank Carrie Favell for typing the manuscript, Nick Taylor for preparing
the illustrations, and David Sallomi for assistance with the statistics.
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
